ARCHIVES

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

IOM Report Says Smoking Bans Cut Heart Attack Risk

October 23, 2009

USPSTF Recommends Hepatitis C Screening For Baby Boomers

June 26, 2013

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

National Comprehensive Center Network, Quintiles Oncology, To Collaborate On Trials

March 5, 1999

NCAB Oks Organ Systems Plan, Criteria For Starting, Ending Working Groups

October 7, 1988

Chemical, Viral Carcinogenesis Should Not Be Separated: Shimkin

July 14, 1978